Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory

Author： Nahleh Zeina  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.4, Iss.1, 2008-02, pp. : 15-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hormone Receptor-Negative Breast Cancer: Undertreatment of Patients Over 80

By Weiss Anna   Noorbaksh Abraham   Tokin Christopher   Chang David   Blair Sarah  

Annals of Surgical Oncology, Vol. 20, Iss. 10, 2013-10 ,pp. : 3274-3278

Springer Publishing Company

Access to resources Recommend Favorite

Shift in cytotoxic target from estrogen receptor-positive to estrogen receptor-negative breast cancer cells by trastuzumab in combination with taxane-based chemotherapy

By              

Oncology Letters, Vol. 2, Iss. 2, 2011-01 ,pp. : 303-308

Spandidos Publications

Access to resources Recommend Favorite

The Androgen Receptor as Putative Therapeutic Target in Hormone-Refractory Prostate Cancer

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 2, Iss. 3, 2007-11 ,pp. : 203-211

Bentham Science Publishers

Access to resources Recommend Favorite

Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer

By Asano Yuka   Kashiwagi Shinichiro   Goto Wataru   Tanaka Sayaka   Morisaki Tamami   Takashima Tsutomu   Noda Satoru   Onoda Naoyoshi   Ohsawa Masahiko   Hirakawa Kosei   Ohira Masaichi  

Cancers, Vol. 9, Iss. 1, 2017-01 ,pp. : 4-4

MDPI

Access to resources Recommend Favorite

Treatment Strategies for Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

By Yang Wei   Chamberlin Mary D.   Miller Todd W.  

The Journal of OncoPathology, Vol. 2, Iss. 2, 2014-06 ,pp. : 33-42

Optimal Clinical Ltd

Access to resources Recommend Favorite